Protein Technologies First Quarter 2009 Earnings on Target for Growth
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
In these difficult economic times, many companies are not so much focused on trying to grow as trying to survive. For Protein Technologies, Inc. (PTI), a private manufacturer of peptide synthesizers in Tucson, AZ, the goal is to grow.
In 2006, PTI was named one of the “Top 50 Arizona Companies to Watch” by the ASBA (Arizona Small Business Association), in collaboration with the Edward Lowe Foundation. This award recognized PTI’s potential for growth due to increased investment in its engineering and chemistry teams.
In the last few years, that potential has been realized. In the niche market of peptide synthesis, PTI was the only peptide synthesizer manufacturer to not only come out with a new instrument, but one each year in 2006 and 2007 (The Prelude and Tribute, respectively). Their design and ability to meet customers’ needs has resulted in double-digit profit growth for PTI in both 2007 and 2008.
First quarter 2009 results are higher than the same quarter last year, which was the best quarter in the history of the company. Based on these results in these difficult economic times, Protein Technologies looks forward to continuing its current growth trend.
“Naturally, we are ecstatic at the results of our investment, and we look forward to continued success in the future!” said Christina Chantell, Chemist and Marketing Coordinator at Protein Technologies. When asked about the current economic climate, Chantell stated, “No one can simply ignore the current economic climate, but we feel our previous investments and growth have put us in a very strong position to weather this economic storm, and weather it very well.”
In 2006, PTI was named one of the “Top 50 Arizona Companies to Watch” by the ASBA (Arizona Small Business Association), in collaboration with the Edward Lowe Foundation. This award recognized PTI’s potential for growth due to increased investment in its engineering and chemistry teams.
In the last few years, that potential has been realized. In the niche market of peptide synthesis, PTI was the only peptide synthesizer manufacturer to not only come out with a new instrument, but one each year in 2006 and 2007 (The Prelude and Tribute, respectively). Their design and ability to meet customers’ needs has resulted in double-digit profit growth for PTI in both 2007 and 2008.
First quarter 2009 results are higher than the same quarter last year, which was the best quarter in the history of the company. Based on these results in these difficult economic times, Protein Technologies looks forward to continuing its current growth trend.
“Naturally, we are ecstatic at the results of our investment, and we look forward to continued success in the future!” said Christina Chantell, Chemist and Marketing Coordinator at Protein Technologies. When asked about the current economic climate, Chantell stated, “No one can simply ignore the current economic climate, but we feel our previous investments and growth have put us in a very strong position to weather this economic storm, and weather it very well.”
